All In MedTech

Device Trial Radar · NCT06748885

Mpact 3D Metal Monolit Study

Prospective, Multicentre, Non-randomised, Open Study Evaluating the Efficacy and Fixation of the Mpact 3D Metal Monolit Cup

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

88

Planned (sponsor's estimate)

Start

Feb 28, 2024

Primary completion

Dec 2030

Study completion Dec 2030

Sponsor

Lead sponsor
Medacta International SANot on our public-company list
Sponsor type
Industry
First posted
Dec 27, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Total hip arthroplasty (THA) is one of the most common operations performed in orthopaedics to improve a patient's quality of life. Surgeons are constantly seeking to improve all aspects of care related to this procedure, whether it be improving implant technology, improving instrumentation or the technique involved in performing the procedure. In recent years, a new porous titanium coating has been introduced to promote good osseointegration of uncemented cups. High friction torque and a feeling of immediate anchorage provide excellent primary stability, while high porosity ensures bone growth providing secondary stability. With higher porosity than standard coatings, a greater volume of bone can be present in the porous surface, giving a proportional increase in force at the interface. he Mpact 3D Metal Monolith cup has been designed to provide greater range of motion and improved joint stability, with a reduced risk of dislocation. It is an innovative design that improves stability and provides a favourable environment for long-term biological metal-bone fixation. The current study aims to collect clinical and radiological data to assess the function of the operated hip and the stability of the Mpact 3D Metal Monolith cup at 2 years and survival at 5 years for the treatment of patients requiring hip arthroplasty.

Conditions

  • Total Hip Arthroplasty (THA)

Interventions

  • Mpact 3D Metal MonolithDevice

    THA with Mpact 3D Metal Monolith

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of the hip functionTime frame: Preoperative, 3 months, 6 months, 1 year, 2 years, 5 years

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Clinique Brétéché

    Nantes, France · Not yet recruiting

  • Hôpital Lariboisière

    Paris, France · Not yet recruiting

  • Hôpital Cochin

    Paris, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.